Fund Holdings — Sarissa Capital Management LP

Total Portfolio Value
$222.91M
Total Bought
$8.79M
Total Sold
$7.15M
Net Transaction
+$1.64M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
IRONWOOD PHARMACEUTICALS INC(IRWD)15,919,43515,919,435020,85453,64824.07%+32,794
BIOHAVEN LTD(BHVN)0513,184+513,18405,7942.60%+5,794
INNOVIVA INC(INVA)2,816,0222,816,022051,39256,29225.25%+4,900
AMARIN CORP PLC1,242,5271,673,395+430,86820,35323,35210.48%+3,000
LANTHEUS HLDGS INC(LNTH)181,450181,45009,30712,0755.42%+2,769
REGENERON PHARMACEUTICALS(REGN)4,1904,19002,3563,2341.45%+878
NEUROCRINE BIOSCIENCES INC(NBIX)303,151303,151042,55642,99619.29%+440
VOR BIOPHARMA INC(VOR)25,39925,39901,2373320.15%-905
CYTOKINETICS INC(CYTK)588,357396,357-192,00032,33625,18511.30%-7,152
Page 1 of 1
Sarissa Capital Management LP — 13F Holdings — Q4 2025 | TickerTrail